search
Back to results

MMP-9 Expression in Permanent Mature Teeth With Symptomatic Pulpitis

Primary Purpose

Pulpitis

Status
Completed
Phase
Not Applicable
Locations
Lithuania
Study Type
Interventional
Intervention
Coronal pulpotomy
Sponsored by
Eglė Gvazdaitytė
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pulpitis focused on measuring Calcium-silicate, coronal pulpotomy, MMP-9, symptomatic pulpitis.

Eligibility Criteria

14 Years - 33 Years (Child, Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Teeth diagnosed with symptomatic pulpitis
  • Patients who did not use any NSAIDs before the treatment
  • Positive cold test of investigated teeth
  • Clinically dental caries in contact with pulp chamber
  • Permanent teeth with radiographically closed root apex

Exclusion Criteria:

  • Patients who refuse to participate in the study
  • Medically compromised patients (with immunosuppressive/systemic diseases, patients on medications)
  • Teeth with periapical radiolucency or clinical signs of apical periodontitis
  • Periodontological compromised teeth (probing depth ≥4mm)
  • Internal/external root resorption in periapical radiograph
  • Pulp chamber and/or root canal calcification in periapical radiograph
  • Teeth with unrestorable crown
  • Teeth with a negative response to cold test

Sites / Locations

  • Lithuanian University of Health Science

Arms of the Study

Arm 1

Arm 2

Arm Type

Other

Experimental

Arm Label

Control group - Healthy teeth

Test group - Teeth with pulpitis

Arm Description

Patients with clinically healthy third molar or premolar teeth with indications for extraction; no clinical signs of pulpitis, no caries, no indications for the replacement of an old filling that is 1 mm from the pulp space as determined on the radiograph; a normal response to the cold test, and no apical radiolucency on the radiograph. For teeth of this group coronal pulpotomy was applied.

Patients with symptomatic pulpitis resulting from caries; tooth pain defined as sharp, dull, localized or diffuse; pain at night; a symptomatic tooth with a positive response to the cold test and lingering pain; intermittent or continuous episodes of spontaneous pain (with no external stimulus) that could last from a few minutes up to a few hours; no apical radiolucency on the radiograph. For teeth of this group coronal pulpotomy was applied.

Outcomes

Primary Outcome Measures

MMP-9 amount measurement using ELISA kit
The MMP-9 amount in the pulp blood samples was measured using the MMP-9 Human ELISA Kit. The measurement procedure was followed according to the manufacturer's instructions. The anti-MMP-9 polyclonal antibody was pre-coated on 96-well plates. Blood samples and a biotin-conjugated antibody were added to the wells supplemented with Avidin-Biotin-Peroxidase Complex and 3,3',5,5'-tetramethylbenzidine in a mildly acidic buffer. A blue-colored product was produced and turned to yellow after an acidic stop solution was added. The intensity of the color yellow was proportional to the MMP-9 amount bound on the plate. The optical density absorbance was measured spectrophotometrically at 450nm in a microplate reader and the concentration of MMP-9 was calculated. For the expression of MMP-9 concentrations in the samples, a standard curve was used.

Secondary Outcome Measures

Full Information

First Posted
November 19, 2018
Last Updated
January 14, 2019
Sponsor
Eglė Gvazdaitytė
search

1. Study Identification

Unique Protocol Identification Number
NCT03807674
Brief Title
MMP-9 Expression in Permanent Mature Teeth With Symptomatic Pulpitis
Official Title
A Prospective Clinical Pilot Study of MMP-9 Expression and Short-term Outcome of Coronal Pulpotomy in Mature Permanent Teeth With Symptomatic Pulpitis
Study Type
Interventional

2. Study Status

Record Verification Date
January 2019
Overall Recruitment Status
Completed
Study Start Date
March 27, 2017 (Actual)
Primary Completion Date
July 15, 2017 (Actual)
Study Completion Date
February 11, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Eglė Gvazdaitytė

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Matrix metallopeptidase-9 (MMP-9) expression was compared in healthy and inflamed pulp and the outcome of coronal pulpotomy in teeth with symptomatic pulpitis was assessed. After procedure blood samples were examined using Elisa kit.
Detailed Description
Introduction: Widely used diagnostic tests do not provide information to distinguish the pulp inflammation stage while improvement of materials, techniques and vital pulp therapy have received a wider acceptance in symptomatic pulpitis treatment. The aim of this clinical study was to compare MMP-9 expression in healthy and inflamed pulp and to assess the short-term outcome of coronal pulpotomy in mature permanent teeth with symptomatic pulpitis. Methods: Patients diagnosed with symptomatic pulpitis were included in this clinical study. Coronal pulpotomy was performed using calcium-silicate based material and blood samples were taken. Initial and postoperative pain was recorded by Heft-Parker visual analog scale at 24 hours and 72 hours after the procedure. In control group teeth with healthy pulp were used. During follow-up visits after three and six-months, patients were examined clinically and radiographically. The ELISA kit was used to determine the levels of MMP-9 in inflamed and healthy coronal pulp tissue.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pulpitis
Keywords
Calcium-silicate, coronal pulpotomy, MMP-9, symptomatic pulpitis.

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
20 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Control group - Healthy teeth
Arm Type
Other
Arm Description
Patients with clinically healthy third molar or premolar teeth with indications for extraction; no clinical signs of pulpitis, no caries, no indications for the replacement of an old filling that is 1 mm from the pulp space as determined on the radiograph; a normal response to the cold test, and no apical radiolucency on the radiograph. For teeth of this group coronal pulpotomy was applied.
Arm Title
Test group - Teeth with pulpitis
Arm Type
Experimental
Arm Description
Patients with symptomatic pulpitis resulting from caries; tooth pain defined as sharp, dull, localized or diffuse; pain at night; a symptomatic tooth with a positive response to the cold test and lingering pain; intermittent or continuous episodes of spontaneous pain (with no external stimulus) that could last from a few minutes up to a few hours; no apical radiolucency on the radiograph. For teeth of this group coronal pulpotomy was applied.
Intervention Type
Procedure
Intervention Name(s)
Coronal pulpotomy
Intervention Description
Coronal pulpotomy was performed with a sterile high-speed round bur under water coolant. Pulp vitality was confirmed by the presence of bleeding pulp tissue from all of the canal orifices. Hemostasis was achieved through the application of a pellet moistened with 2.5% NaOCl for two minutes and was repeated as needed. Calcium-silicate based material was prepared ac-cording to the manufacturer's instructions and gently placed over the pulp to fill the entire cavity.
Primary Outcome Measure Information:
Title
MMP-9 amount measurement using ELISA kit
Description
The MMP-9 amount in the pulp blood samples was measured using the MMP-9 Human ELISA Kit. The measurement procedure was followed according to the manufacturer's instructions. The anti-MMP-9 polyclonal antibody was pre-coated on 96-well plates. Blood samples and a biotin-conjugated antibody were added to the wells supplemented with Avidin-Biotin-Peroxidase Complex and 3,3',5,5'-tetramethylbenzidine in a mildly acidic buffer. A blue-colored product was produced and turned to yellow after an acidic stop solution was added. The intensity of the color yellow was proportional to the MMP-9 amount bound on the plate. The optical density absorbance was measured spectrophotometrically at 450nm in a microplate reader and the concentration of MMP-9 was calculated. For the expression of MMP-9 concentrations in the samples, a standard curve was used.
Time Frame
All samples were measured in one time (during 12 hours)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
14 Years
Maximum Age & Unit of Time
33 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Teeth diagnosed with symptomatic pulpitis Patients who did not use any NSAIDs before the treatment Positive cold test of investigated teeth Clinically dental caries in contact with pulp chamber Permanent teeth with radiographically closed root apex Exclusion Criteria: Patients who refuse to participate in the study Medically compromised patients (with immunosuppressive/systemic diseases, patients on medications) Teeth with periapical radiolucency or clinical signs of apical periodontitis Periodontological compromised teeth (probing depth ≥4mm) Internal/external root resorption in periapical radiograph Pulp chamber and/or root canal calcification in periapical radiograph Teeth with unrestorable crown Teeth with a negative response to cold test
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Greta Lodiene
Organizational Affiliation
Lithuanian University of Health Science
Official's Role
Study Director
Facility Information:
Facility Name
Lithuanian University of Health Science
City
Kaunas
Country
Lithuania

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

MMP-9 Expression in Permanent Mature Teeth With Symptomatic Pulpitis

We'll reach out to this number within 24 hrs